Luying Shi

No ORCID on file · 4 papers in corpus · active 2021-2024

Study types

  • article 2
  • dataset 2

Condition tags

  • adenomyosis 4
  • dysmenorrhea 1
article 2024
PeerJ ·doi:10.7717/peerj.16784

BACKGROUND: Investigating the relationship between cyclooxygenase-2 (COX-2) pathway-related factors and clinical features in patients with adenomyosis by proteomics could provide potential therapeutic targets. METHODS: This study recruited…

dataset 2023
·doi:10.5281/zenodo.8281116

Peptide, protein, protein_merge_info and psm are part of mass spectrometry. HE and LE, only LE and only HE are part of bioinformatics analysis.

dataset 2023
·doi:10.5281/zenodo.8281115

Peptide, protein, protein_merge_info and psm are part of mass spectrometry. HE and LE, only LE and only HE are part of bioinformatics analysis.

article 2021
American journal of translational research

OBJECTIVE: This study aimed to explore the effect of COX-2 selective inhibitor (celecoxib) on adenomyosis and its mechanism. METHODS: By establishing a mouse model of adenomyosis and using celecoxib to treat adenomyosis, newly born female m…